TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Items tagged with Scientific research

Latest TB research publications (post)

The March issue of The Lancet Infectious Diseases contains a number of TB publications available free of charge after registration.

Texas Biomed scientists developing new vaccine strategy for TB (post)

For years, scientists have been trying to come up with a better way to protect people against tuberculosis, the disease caused by infection with the Mycobacterium tuberculosis (Mtb) bacteria. Texas Biomedical Research Institute Professor Jordi Torrelles, Ph.D., says new hope is on the horizon after a recent experiment performed in mice showed great promise. The study was published in the journal Mucosal Immunology.

Cleaning up TB and salmonella infections (post)

The cellular recycling system in zebrafish is capable of eating harmful bacteria and thus resist infections such as tuberculosis and salmonellosis. That is written by Leiden biologists from the group of Annemarie Meijer. Stimulating this form of defence could be used in new treatment methods against infectious diseases. The researchers publish their results in two leading journals, Autophagy and PLOS Pathogens.

Lab in South African “township” to sample TB from breathed air (post)

A new facility located in a congested community with high tuberculosis rates brings basic science and cutting edge techniques into the heart of disease circulation.

Research demonstrates how immunotherapy may be effective for fighting TB (post)

In part because of its resistance to many antibiotics, tuberculosis kills approximately 1.7 million people worldwide each year. But new research from the University of Notre Dame suggests that structures released by the infected cells may be used in tandem with antibiotics to boost the body’s immune system, helping fight off the disease.

Reducing the burden of TB treatment (post)

Tuberculosis is one of the world's deadliest infectious diseases: One-third of the world's population is infected with TB, and more than 1 million people die from the disease every year.

PLOS Special Collection launch: Shaping novel TB treatments (post)

To commemorate World TB Day, a Special Collection has been released by PLOS Medicine containing a series of articles that articulate the essential new steps in clinical research that will pave the way for the development of tomorrow's optimal treatment for all forms of tuberculosis. This Special Collection is sponsored by the World Health Organization (WHO) and the French National Research Institute for Sustainable Development (IRD-France), and is co-ordinated by Dr Christian Lienhardt, Research Director at IRD-France and Dr Payam Nahid, Professor at University of California, San Francisco, USA.

Anti-TB drugs can increase risk of TB re-infection (post)

Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don’t, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.

Supercomputer simulations help combat TB granulomas (post)

The greatest cause of death due to infection globally is tuberculosis (TB). Two supercomputers – Comet at the San Diego Supercomputer Center (SDSC) at UC San Diego and Stampede2 at the Texas Advanced Computer Center (TACC) at the University of Texas at Austin – are being used to help combat this lethal disease.

Aspirin to fight an expensive global killer infection (post)

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.

Page 38 of 74 · Total posts: 0

←First 37 38 39 Last→